Taztia XT — Class I drug recall D-1446-2014
Terminated recall by Shamrock Medical Solutions Group LLC, reported 2014-07-30, distributed in CO, MA, OH, TX, WY. Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules
| Recall number | D-1446-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Shamrock Medical Solutions Group LLC, Lewis Center, OH, United States |
| Recall initiated | 2011-09-27 |
| Classified | 2014-07-23 |
| Reported by FDA | 2014-07-30 |
| Terminated | 2014-07-31 |
| Distributed | CO, MA, OH, TX, WY |
| Quantity | 89 |
| Reason classes | labeling |
| NDC | 62037-0696-90 |
| Lot numbers | 0021OC |
| Expiration dates | 2013-05-31 |
Product
Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90
Reason for recall
Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1446-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.